In vitro maturation
Article first published online: 16 SEP 2013
© 2013 Royal College of Obstetricians and Gynaecologists
The Obstetrician & Gynaecologist
Volume 15, Issue 4, pages 215–219, October 2013
How to Cite
In vitro maturation. The Obstetrician & Gynaecologist 2013;15:215–9., .
- Issue published online: 16 OCT 2013
- Article first published online: 16 SEP 2013
- Manuscript Accepted: 10 FEB 2012
- in vitro fertilisation;
- in vitro maturation;
- polycystic ovary syndrome
- In vitro maturation is an alternative to in vitro fertilisation for young women with polycystic ovary syndrome and young ovulatory women.
- In vitro maturation accomplishes the maturation of immature oocytes in the laboratory, thus minimising or avoiding gonadotrophin stimulation and the associated cost, side-effects and risks.
- Pregnancy rates are lower with in vitro maturation than with in vitro fertilisation.
- To define appropriate candidates for in vitro maturation.
- To review variations in protocols and laboratory aspects of in vitro maturation and the rationale for these variations.
- To highlight outcome data from in vitro maturation cycles.
- Infertile couples must consider both the risks and benefits of in vitro maturation and make an informed decision regarding their treatment options.
- Further long-term outcome data regarding the health of children born through in vitro maturation is necessary.